NDAQ:MNMD - Post Discussion
Post by
whytestocks on Mar 08, 2024 1:45pm
MindMeds Systematic Biotech Approach With New FDA Therapy De
JUST IN: $MNMD MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds | BenzingaShortly following the news on FDA's "breakthrough therapy" designation and the 12-week clinical durability data on its LSD therapy for general...
MNMD - MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds | Benzinga
Be the first to comment on this post